Prognosis and risk factors for cardiac valve calcification in Chinese end-stage kidney disease patients on combination therapy with hemodialysis and hemodiafiltration
- PMID: 35166181
- PMCID: PMC8856035
- DOI: 10.1080/0886022X.2022.2032742
Prognosis and risk factors for cardiac valve calcification in Chinese end-stage kidney disease patients on combination therapy with hemodialysis and hemodiafiltration
Abstract
Background: Cardiac valve calcification (CVC) is an important risk factor for cardiovascular complications. However, limited data are available concerning the prevalence, clinical features and risk factors for CVC in end-stage kidney disease (ESKD) patients. In this study, we aimed to assess these parameters in Chinese ESKD patients receiving combination therapy with hemodialysis and hemodiafiltration.
Methods: We conducted a cross-sectional study on 293 ESKD patients undergoing combination therapy of hemodialysis and hemodiafiltration at the First Affiliated Hospital of Chongqing Medical University from October 2014 to December 2015. CVC was evaluated via echocardiography.
Results: ESKD patients with CVC had a higher prevalence of diabetes mellitus, aortic and/or coronary artery calcification, arrhythmia, heart failure and coronary heart disease; increased systolic, diastolic and pulse pressure; longer duration of hemodialysis and hypertension; reduced hemoglobin, albumin and high-density lipoprotein cholesterol levels; and increased serum calcium and calcium-phosphorus product levels compared with those without CVC. Logistic regression analysis showed that increased dialysis duration (p = 0.006, OR = 2.25), serum calcium levels (p = 0.046, OR = 2.04) and pulse pressure (p < 0.001, OR = 3.22), the presence of diabetes (p = 0.037, OR = 1.81) and decreased serum albumin levels (p = 0.047, OR = 0.54) were risk factors for CVC. The correlation analysis indicated a significantly increased CVCs prevalence with an increase prevalence of heart failure, aortic and coronary artery calcification.
Conclusions: CVC represents a common complication and a danger signal for cardiovascular events in ESKD patients undergoing combination therapy of hemodialysis and hemodiafiltration. The presence of diabetes, increased pulse pressure, long dialysis duration, hypoalbuminemia and high serum calcium levels were independent risk factors for CVC.
Keywords: End-stage kidney disease; cardiac valve calcification; hemodiafiltration; hemodialysis; vascular calcification.
Figures



Similar articles
-
Malnutrition as a risk factor for cardiac valve calcification in patients under maintenance dialysis: a cross-sectional study.Int Urol Nephrol. 2020 Nov;52(11):2205-2212. doi: 10.1007/s11255-020-02590-z. Epub 2020 Sep 22. Int Urol Nephrol. 2020. PMID: 32964341
-
Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis.BMC Cardiovasc Disord. 2020 Jan 30;20(1):39. doi: 10.1186/s12872-020-01343-1. BMC Cardiovasc Disord. 2020. PMID: 32000687 Free PMC article.
-
De novo Cardiac Valve Calcification after Hemodialysis in End-Stage Renal Disease Patients Predicts Future Cardiovascular Events: A Longitudinal Cohort Study.Cardiorenal Med. 2019;9(4):229-239. doi: 10.1159/000494701. Epub 2019 Apr 17. Cardiorenal Med. 2019. PMID: 30995648
-
Association between serum beclin 1 level and cardiac valvular calcification in hemodialysis patients.Curr Probl Cardiol. 2024 May;49(5):102519. doi: 10.1016/j.cpcardiol.2024.102519. Epub 2024 Mar 16. Curr Probl Cardiol. 2024. PMID: 38492612 Review.
-
Risk factors for coronary artery calcification in Chinese patients undergoing maintenance hemodialysis: a meta-analysis.Int Urol Nephrol. 2025 May 2. doi: 10.1007/s11255-025-04535-w. Online ahead of print. Int Urol Nephrol. 2025. PMID: 40314886 Review.
Cited by
-
Cardiac valve calcification as a predictor of cardiovascular outcomes in peritoneal dialysis patients: an inverse probability of treatment weighting analysis.Int Urol Nephrol. 2023 May;55(5):1271-1278. doi: 10.1007/s11255-022-03430-y. Epub 2022 Dec 1. Int Urol Nephrol. 2023. PMID: 36454448
-
Abdominal aortic calcification score can predict all-cause and cardiovascular mortality in maintenance hemodialysis patients.Ren Fail. 2023 Dec;45(1):2158869. doi: 10.1080/0886022X.2022.2158869. Ren Fail. 2023. PMID: 36637006 Free PMC article.
-
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients.Clin Kidney J. 2024 Feb 15;17(3):sfae038. doi: 10.1093/ckj/sfae038. eCollection 2024 Mar. Clin Kidney J. 2024. PMID: 38524234 Free PMC article.
-
Influencing factors of cardiac valve calcification (CVC) in patients with chronic kidney disease and the impact of CVC on long-term prognosis: a single-center retrospective study.PeerJ. 2023 Jun 30;11:e15569. doi: 10.7717/peerj.15569. eCollection 2023. PeerJ. 2023. PMID: 37404480 Free PMC article.
-
Correlation between visceral fat area and cardiac valve calcification in hemodialysis patients.Front Cardiovasc Med. 2025 Apr 10;12:1574649. doi: 10.3389/fcvm.2025.1574649. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40276255 Free PMC article.
References
-
- Wang AY, Wang M, Woo J, et al. . Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. JASN. 2003;14(1):159–168. - PubMed
-
- Li M, Ye ZC, Li CM, et al. . The influence of cardiac valvular calcification on all-cause and cardiovascular mortality in maintenance hemodialysis patients. Int Urol Nephrol. 2020;52(5):943–951. - PubMed
-
- Braun J, Oldendorf M, Moshage W, et al. . Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27(3):394–401. - PubMed
-
- Zapolski T, Wysokiński A, Janicka L, et al. . Aortic stiffness and valvular calcifications in patients with end-stage renal disease. Pol Arch Med Wewn. 2008;118(3):111–118. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical